stars 1 stars 2 stars 3

hemotune offers a versatile platform for targeted magnetic separation By merging nanotechnology with advanced engineering, hemotune has created a versatile platform for highly selective, efficient, and scalable magnetic separation. In medicine, this means removing disease triggers and harmful agents directly from the bloodstream instead of adding compounds, aiming to reduce side effects and enable multi-target strategies. Tunable for applications in healthcare and high-value processes, the platform delivers precision and flexibility across the entire value chain.

hemotune AG Questions

Lukas Langenegger is the CEO and co-founder of hemotune AG.

20 people are employed at hemotune AG.

hemotune AG is based in Schlieren, Zurich.

Top hemotune AG Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users